Brexucabtagene autoleucel Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with brexucabtagene autoleucel
R
- RabAvert (rabies vaccine, purified chick embryo cell)
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- Raptiva (efalizumab)
- Raxar (grepafloxacin)
- Rayos (prednisone)
- Recombivax HB (hepatitis b pediatric vaccine)
- Recombivax HB Adult (hepatitis b adult vaccine)
- Recombivax HB Dialysis Formulation (hepatitis b adult vaccine)
- Recombivax HB Pediatric / Adolescent (hepatitis b pediatric vaccine)
- Releuko (filgrastim)
- Remicade (infliximab)
- Renflexis (infliximab)
- Restora (lactobacillus casei / omega-3 polyunsaturated fatty acids)
- Restora Rx (folic acid / lactobacillus casei)
- Rethymic (allogeneic processed thymus tissue)
- Retrovir (zidovudine)
- Rezyst (bifidobacterium infantis / lactobacillus acidophilus)
- ReZyst IM (bifidobacterium infantis / lactobacillus acidophilus)
- rilonacept
- Rinvoq (upadacitinib)
- Rinvoq LQ (upadacitinib)
- Risa-Bid (lactobacillus acidophilus)
- RisaQuad (lactobacillus acidophilus)
- RisaQuad 2 (lactobacillus acidophilus)
- ritlecitinib
- roflumilast
- Rolvedon (eflapegrastim)
- ropeginterferon alfa-2b
- Rotarix (rotavirus vaccine)
- RotaShield (rotavirus vaccine)
- RotaTeq (rotavirus vaccine)
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- Ryzneuta (efbemalenograstim alfa)
More about brexucabtagene autoleucel
- brexucabtagene autoleucel consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.